Lecturer David Korn | Consortium on Law and Values in Health, Environment & the Life Sciences

Quick Links

View Video Online Duration: 90 minutes
RealPlayer is required to view video. Free Download

Dr. Korn is the Senior Vice President for Biomedical and Health Sciences Research at the Association of American Medical Colleges (AAMC) in Washington, D.C. He previously served as Carl and Elizabeth Naumann Professor and Dean of the Stanford University School of Medicine and as Vice President of Stanford University. He was a founder of the California Transplant Donor Network and more recently, a founder of the Association for the Accreditation of Human Research Protection Programs, a nonprofit member corporation created to enhance and make more uniform the protection of human participants in medical research. He is a member of the Institute of Medicine of the National Academy of Sciences, and a founder of the Clinical Research Roundtable. His recent research and writing focuses on issues of health and science policy, topics in which he has been heavily engaged on the national scene.

More Information

Financial Conflicts of Interest in Biomedical Research

David Korn, MD
Association of American Medical Colleges

Wednesday, March 10, 2004
11:30AM - 1:00PM
Theater
Coffman Memorial Union

Dramatic advances in biomedical research have been accompanied by an equally dramatic deepening of financial relationships between medical faculty and their institutions with industry sponsors and patrons, and this trend will only intensify in coming years. Research universities and their academic medical centers are increasingly exhorted by political leaders to serve as engines of local and regional socio-economic improvement. Yet the public continues to expect that academic research, and especially clinical research, will be free from any taint of financial conflict of interest. In the face of this serious conflict of public expectation, how best can we protect the welfare of human research participants, investigators, and universities, as well as the integrity of science, while continuing vigorously to facilitate the translation of publicly funded biomedical research discoveries into public benefit?

Commentators:


Prof. Norman Bowie Carlson School of Management, University of Minnesota		Prof. David Hamilton Interim Vice President for Research, University of Minnesota